tiprankstipranks
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
US Market

BioNano Genomics (BNGO) Income Statement

Compare
9,178 Followers

BioNano Genomics Income Statement

Last quarter (Q3 2024), BioNano Genomics's total revenue was $6.07M, a decrease of -34.83% from the same quarter last year. In Q3, BioNano Genomics's net income was $-44.25M. See BioNano Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 36.12M$ 27.80M$ 17.98M$ 8.50M$ 10.13M
Gross Profit
$ 9.57M$ 5.95M$ 3.87M$ 2.77M$ 3.36M
Operating Expenses
$ 224.81M$ 137.64M$ 80.97M$ 41.32M$ 29.24M
Depreciation and Amortization
$ 13.71M$ 10.10M$ 3.97M$ 1.47M$ 1.13M
EBITDA
$ -213.60M$ -120.31M$ -73.86M$ -37.08M$ -26.38M
Operating Income
$ -215.25M$ -131.70M$ -77.10M$ -38.55M$ -25.87M
Other Income/Expenses
$ -17.19M$ 986.00K$ -1.05M$ -2.53M$ -3.92M
Pretax Income
$ -232.43M$ -130.71M$ -78.15M$ -41.11M$ -29.82M
Net Income
$ -232.49M$ -132.60M$ -72.44M$ -41.14M$ -29.84M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.81$ -4.58$ -2.62$ -3.95$ -19.92
Diluted EPS
$ -6.81$ -4.58$ -2.62$ -3.95$ -19.92
Weighted Average Shares Outstanding
34.15M 28.92M 27.68M 10.43M 1.50M
Weighted Average Shares Outstanding (Diluted)
34.15M 28.92M 27.68M 10.43M 1.50M
Currency in USD

BioNano Genomics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis